In Vitro Fertilization Market Analysis and Forecast to 2031: By Product (Equipment, Reagent & Media, Accessories), Cycle (Fresh Non-donor, Frozen Non-donor, Frozen Donor, Fresh Donor), Type (Conventional IVF, IVF With ICSI, IVF with Donor Eggs, Others), E
Description
In Vitro Fertilization Market Analysis and Forecast to 2031: By Product (Equipment, Reagent & Media, Accessories), Cycle (Fresh Non-donor, Frozen Non-donor, Frozen Donor, Fresh Donor), Type (Conventional IVF, IVF With ICSI, IVF with Donor Eggs, Others), End User (Fertility Clinics, Hospitals & Surgical Centers, Cryobanks, Research Institutes), and Region
The global in vitro fertilization market was valued at USD 628 Million in 2021 and it is anticipated to grow further up to USD 1520 Million by 2031, at a CAGR of 9.2% during the forecast period.
IVF is one of the frequently utilized procedures that helped infertile couples, single mothers, and members of the LGBT community have children. The growth of the in vitro fertilization market is driven by an increase in the rate of infertility, a rise in the trend of delayed pregnancies, a surge in the success rate of IVF treatment, technological advancements in IVF treatment, an increase in the rate of infertility and practices of embryo banking cycles, and an increase in disposable income in the United States. In addition, rising IVF use in the US, rising rates of infertility and embryo banking, technological developments in IVF treatment, and trends toward delayed pregnancy are all anticipated to pave the way for future growth of the US IVF industry.
Market Trends and Drivers
Globally, the median age of first-time mothers has dramatically risen over time. This trend is largely due to more effective methods of contraception, later marriages, and the rise in the proportion of women who prioritize their professions over having children. Data from the Australian Institute of Health and Welfare 2021 show that first-time moms in Australia are now, on average, 31.9 years old, up from 27.9 years in 2009. More women are anticipated to experience difficulties conceiving naturally as the typical age of first-time mothers rises. In this situation, more and more ladies are being compelled to choose IVF procedures, which is anticipated to fuel the market's expansion in the ensuing years.
Market Restraints and Challenges
Around the world, more than 2.5 million IVF cycles are carried out annually. Due to the absence of reimbursement policies, the cost of IVF therapy varies from nation to nation. The development of this market is being constrained by a lack of insurance coverage and a problematic reimbursement environment in several regions of the world.
Global In Vitro Fertilization Market Segmental Overview
The report analyses the global in vitro fertilization market based on the product, cycle, type, end user, and region.
Global In Vitro Fertilization Market by Product
Based on the product, it is segmented into equipment, reagents & media, and accessories. The equipment segment is likely to capture the largest share in the market. The high growth in this segment is primarily attributed to the increasing number of IVF procedures and the introduction of highly advanced IVF equipment by well-established manufacturers in the market.
Global In Vitro Fertilization Market by Cycle
Based on the cycle, it is segmented into fresh non-donor IVF cycles, frozen non-donor IVF cycles, frozen donor IVF cycles, and fresh donor IVF cycles. The fresh non-donor segment is anticipated to hold the majority of the market share during the forecast period. The key factors such as high success rates, ease in the implantation process, and enhanced embryo production are responsible for the large share of this segment.
Global In Vitro Fertilization Market by Type
Based on the type, it is segmented into conventional IVF, IVF with ICSI, IVF with donor eggs, and others. The IVF with ICSI segment is likely to register the highest market share during the projection period. The success rate of fertilization with ICSI procedure, and the growing utilization of the ICSI during IVF procedures are anticipated to boost the adoption of IVF with ICSI procedures are boosting the growth of the market.
Global In Vitro Fertilization Market by End User
Based on the end user, it is segmented into fertility clinics, hospitals & surgical centers, cryobanks, and research institutes. The fertility clinics segment accounted for the largest share of the in vitro fertilization market. The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, the growing popularity of IVF & ICSI treatment across the globe are refueling the growth of the market.
Geographical Analysis of In Vitro Fertilization Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is anticipated to dominate the market during the forecast period. Significant increase in medical travel, growing acceptance of assisted reproductive technology in emerging countries, increased awareness of the availability of in vitro fertilization procedures, fewer IVF treatments performed, expanding fertility clinics in the area, and rising healthcare costs are boosting the growth of the region.
Major Players in the Global In Vitro Fertilization Market
COVID-19 Impact
The worldwide stoppage of in vitro fertilization therapy because to the COVID-19 epidemic had a significant effect on the women having IVF operations. Only 5 lakhs of the 30-lakh people who seek IVF in India each year really go through the IVF/intrauterine insemination (IUI) process. In the world during the COVID-19 epidemic, there was a 90% decrease in the number of IVF procedures. The spread of COVID-19 has had an effect on fertility decisions among couples who had previously chosen IVF therapy, as well as on fertility clinics due to the cancellation of IVF procedures.
Recent Developments
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
The global in vitro fertilization market was valued at USD 628 Million in 2021 and it is anticipated to grow further up to USD 1520 Million by 2031, at a CAGR of 9.2% during the forecast period.
IVF is one of the frequently utilized procedures that helped infertile couples, single mothers, and members of the LGBT community have children. The growth of the in vitro fertilization market is driven by an increase in the rate of infertility, a rise in the trend of delayed pregnancies, a surge in the success rate of IVF treatment, technological advancements in IVF treatment, an increase in the rate of infertility and practices of embryo banking cycles, and an increase in disposable income in the United States. In addition, rising IVF use in the US, rising rates of infertility and embryo banking, technological developments in IVF treatment, and trends toward delayed pregnancy are all anticipated to pave the way for future growth of the US IVF industry.
Market Trends and Drivers
Globally, the median age of first-time mothers has dramatically risen over time. This trend is largely due to more effective methods of contraception, later marriages, and the rise in the proportion of women who prioritize their professions over having children. Data from the Australian Institute of Health and Welfare 2021 show that first-time moms in Australia are now, on average, 31.9 years old, up from 27.9 years in 2009. More women are anticipated to experience difficulties conceiving naturally as the typical age of first-time mothers rises. In this situation, more and more ladies are being compelled to choose IVF procedures, which is anticipated to fuel the market's expansion in the ensuing years.
Market Restraints and Challenges
Around the world, more than 2.5 million IVF cycles are carried out annually. Due to the absence of reimbursement policies, the cost of IVF therapy varies from nation to nation. The development of this market is being constrained by a lack of insurance coverage and a problematic reimbursement environment in several regions of the world.
Global In Vitro Fertilization Market Segmental Overview
The report analyses the global in vitro fertilization market based on the product, cycle, type, end user, and region.
Global In Vitro Fertilization Market by Product
Based on the product, it is segmented into equipment, reagents & media, and accessories. The equipment segment is likely to capture the largest share in the market. The high growth in this segment is primarily attributed to the increasing number of IVF procedures and the introduction of highly advanced IVF equipment by well-established manufacturers in the market.
Global In Vitro Fertilization Market by Cycle
Based on the cycle, it is segmented into fresh non-donor IVF cycles, frozen non-donor IVF cycles, frozen donor IVF cycles, and fresh donor IVF cycles. The fresh non-donor segment is anticipated to hold the majority of the market share during the forecast period. The key factors such as high success rates, ease in the implantation process, and enhanced embryo production are responsible for the large share of this segment.
Global In Vitro Fertilization Market by Type
Based on the type, it is segmented into conventional IVF, IVF with ICSI, IVF with donor eggs, and others. The IVF with ICSI segment is likely to register the highest market share during the projection period. The success rate of fertilization with ICSI procedure, and the growing utilization of the ICSI during IVF procedures are anticipated to boost the adoption of IVF with ICSI procedures are boosting the growth of the market.
Global In Vitro Fertilization Market by End User
Based on the end user, it is segmented into fertility clinics, hospitals & surgical centers, cryobanks, and research institutes. The fertility clinics segment accounted for the largest share of the in vitro fertilization market. The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, the growing popularity of IVF & ICSI treatment across the globe are refueling the growth of the market.
Geographical Analysis of In Vitro Fertilization Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is anticipated to dominate the market during the forecast period. Significant increase in medical travel, growing acceptance of assisted reproductive technology in emerging countries, increased awareness of the availability of in vitro fertilization procedures, fewer IVF treatments performed, expanding fertility clinics in the area, and rising healthcare costs are boosting the growth of the region.
Major Players in the Global In Vitro Fertilization Market
COVID-19 Impact
The worldwide stoppage of in vitro fertilization therapy because to the COVID-19 epidemic had a significant effect on the women having IVF operations. Only 5 lakhs of the 30-lakh people who seek IVF in India each year really go through the IVF/intrauterine insemination (IUI) process. In the world during the COVID-19 epidemic, there was a 90% decrease in the number of IVF procedures. The spread of COVID-19 has had an effect on fertility decisions among couples who had previously chosen IVF therapy, as well as on fertility clinics due to the cancellation of IVF procedures.
Recent Developments
- July 2021, Hamilton Thorne Ltd. Received FDA approval for the commercialization of the GYNEMED GM501, a ready to use medium designed for in vitro washing and handling procedures of human oocytes and embryos in the US and Europe.
- February 2021, Cooper Surgical announced a partnership with Virtus Health to strengthen its fertility technology, increasing the accessibility of advanced treatment to infertile couples.
- November 2020, Genea Limited collaborated with Hamilton Thorne Ltd. To commercialize Genea limited fertility products in the US and Canada.
- November 2020, FUJIFILM Irvine Scientific announced the launch of Vit Kit-NX, a vitrification media solution.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
159 Pages
- Chapter 1. Market Introduction
- 1.1. Objectives Of the Study
- 1.2. Market Definition and Research & Scope
- 1.3. Research Methodologies
- 1.4. Market Estimation Techniques
- Chapter 2. Executive Summary
- 2.1. Summary
- 2.2. Key Highlights of The Market
- Chapter 3. In Vitro Fertilization Market Outlook
- 3.1. In Vitro Fertilization Market Segmentation
- 3.2. Market Dynamics
- 3.2.1. Market Drivers
- 3.2.1.1. Driver 1
- 3.2.1.2. Driver 2
- 3.2.1.3. Driver 3
- 3.2.2. Market Restraints
- 3.2.2.1. Restraint 1
- 3.2.2.2. Restraint 2
- 3.2.3. Market Opportunities
- 3.2.3.1. Opportunity 1
- 3.2.3.2. Opportunity 2
- 3.3. Porter’s Five Forces Analysis
- 3.3.1. Threat Of New Entrants
- 3.3.2. Threat Of Substitutes
- 3.3.3. Bargaining Power of Buyers
- 3.3.4. Bargaining Power of Supplier
- 3.3.5. Competitive Rivalry
- 3.4. Pestle Analysis
- 3.5. Value Chain Analysis
- 3.5.1. Raw Material Suppliers
- 3.5.2. Manufacturers
- 3.5.3. Wholesalers And/or Retailers
- 3.6. Impact Of the Russia and Ukraine War on The Global In Vitro Fertilization Market
- Chapter 4. The Economic Impact of Covid-19
- 4.1. Overall Impact of Covid-19
- 4.2. Impact Of Covid on The Global In Vitro Fertilization Market
- 4.3. Economic Impact Analysis
- Chapter 5. In Vitro Fertilization Market by Product
- 5.1. Market Overview
- 5.2. Equipment
- 5.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.3. Reagents & Kits
- 5.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.4. Accessories
- 5.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 6. In Vitro Fertilization Market by Cycle
- 6.1. Market Overview
- 6.2. Fresh Non-Donor IVF Cycle
- 6.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 6.3. Frozen Non-Donor IVF Cycles
- 6.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 6.4. Frozen Donor IVF Cycles
- 6.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 6.5. Fresh Donor IVF Cycle
- 6.5.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 7. In Vitro Fertilization Market by Type
- 7.1. Market Overview
- 7.2. Conventional IVF
- 7.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 7.3. IVF With ICSI
- 7.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 7.4. IVF With Donor Eggs
- 7.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 7.5. Others
- 7.5.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 8. In Vitro Fertilization Market by End User
- 8.1. Market Overview
- 8.2. Fertility Clinics
- 8.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.3. Hospitals & Surgical Centers
- 8.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.4. Cryobanks
- 8.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.5. Research Institutes
- 8.5.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 9. Global In Vitro Fertilization Market, By Region
- 9.1. Overview
- 9.2. North America
- 9.2.1. Key Market Trends and Opportunities
- 9.2.2. North America In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.2.3. North America In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.2.4. North America In Vitro Fertilization Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.2.5. The U.S.
- 9.2.5.1. The U.S. In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.2.5.2. The U.S. In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.2.6. Canada
- 9.2.6.1. Canada In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.2.6.2. Canada In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.2.7. Mexico
- 9.2.7.1. Mexico In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.2.7.2. Mexico In Vitro Fertilization Market Size and Forecast by End User Cycle, 2021-2031, ($Million)
- 9.3. Europe
- 9.3.1. Key Market Trends and Opportunities
- 9.3.2. Europe In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.3.3. Europe In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.4. Europe In Vitro Fertilization Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.3.5. Germany
- 9.3.5.1. Germany In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.3.5.2. Germany In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.6. France
- 9.3.6.1. France In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.3.6.2. France In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.7. U.K.
- 9.3.7.1. U.K. In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.3.7.2. U.K. In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.8. Spain
- 9.3.8.1. Spain In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.3.8.2. Spain In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.9. Italy
- 9.3.9.1. Italy In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.3.9.2. Italy In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.10. Russia
- 9.3.10.1. Russia In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.3.10.2. Russia In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.11. Rest Of Europe
- 9.3.11.1. Rest Of Europe In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.3.11.2. Rest Of Europe In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4. Asia-Pacific
- 9.4.1. Key Market Trends and Opportunities
- 9.4.2. Asia-Pacific In Vitro Fertilization Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.4.3. Asia-Pacific In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.4.4. Asia-Pacific In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.5. China
- 9.4.5.1. China In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.4.5.2. China In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.6. India
- 9.4.6.1. India In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.4.6.2. India In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.7. Japan
- 9.4.7.1. Japan In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.4.7.2. Japan In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.8. South Korea
- 9.4.8.1. South Korea In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.4.8.2. South Korea In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.9. Rest Of APAC
- 9.4.9.1. Rest Of APAC In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.4.9.2. Rest Of APAC In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5. Rest Of the World
- 9.5.1. Key Market Trends and Opportunities
- 9.5.2. Rest Of the World In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.5.3. Rest Of the World In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5.4. Rest Of the World In Vitro Fertilization Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.5.5. Latin America
- 9.5.5.1. Latin America In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.5.5.2. Latin America In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5.6. Middle East
- 9.5.6.1. Middle East In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.5.6.2. Middle East In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5.7. Africa
- 9.5.7.1. Africa In Vitro Fertilization Market Size and Forecast by Cycle, 2021-2031, ($Million)
- 9.5.7.2. Africa In Vitro Fertilization Market Size and Forecast by End User, 2021-2031, ($Million)
- Chapter 10. Competitive Landscape
- 10.1. Market Overview
- 10.2. Market Share Analysis/Key Player Positioning
- 10.3. Developmental Strategy Benchmarking
- 10.3.1. New End User Development
- 10.3.2. Cycle Launches
- 10.3.3. Business Expansions
- 10.3.4. Partnerships, Joint Ventures, And Collaborations
- 10.3.5. Mergers And Acquisitions
- Chapter 11. Company Profiles
- 11.1. The Cooper Companies Inc.
- 11.1.1. Company Snapshot
- 11.1.2. Financial Performance
- 11.1.3. Cycle Offerings
- 11.1.4. Key Strategic Initiatives
- 11.1.5. SWOT Analysis
- 11.2. Cook Group
- 11.2.1. Company Snapshot
- 11.2.2. Financial Performance
- 11.2.3. Cycle Offerings
- 11.2.4. Key Strategic Initiatives
- 11.2.5. SWOT Analysis
- 11.3. Vitrolife
- 11.3.1. Company Snapshot
- 11.3.2. Financial Performance
- 11.3.3. Cycle Offerings
- 11.3.4. Key Strategic Initiatives
- 11.3.5. SWOT Analysis
- 11.4. Thermo Fisher Scientific, Inc.
- 11.4.1. Company Snapshot
- 11.4.2. Financial Performance
- 11.4.3. Cycle Offerings
- 11.4.4. Key Strategic Initiatives
- 11.4.5. SWOT Analysis
- 11.5. Esco Micro Pte. Ltd.
- 11.5.1. Company Snapshot
- 11.5.2. Financial Performance
- 11.5.3. Cycle Offerings
- 11.5.4. Key Strategic Initiatives
- 11.5.5. SWOT Analysis
- 11.6. Genea Limited
- 11.6.1. Company Snapshot
- 11.6.2. Financial Performance
- 11.6.3. Cycle Offerings
- 11.6.4. Key Strategic Initiatives
- 11.6.5. SWOT Analysis
- 11.7. IVFtech ApS
- 11.7.1. Company Snapshot
- 11.7.2. Financial Performance
- 11.7.3. Cycle Offerings
- 11.7.4. Key Strategic Initiatives
- 11.7.5. SWOT Analysis
- 11.8. FUJIFILM Irvine Scientific
- 11.8.1. Company Snapshot
- 11.8.2. Financial Performance
- 11.8.3. Cycle Offerings
- 11.8.4. Key Strategic Initiatives
- 11.8.5. SWOT Analysis
- 11.9. The Baker Company, Inc.
- 11.9.1. Company Snapshot
- 11.9.2. Financial Performance
- 11.9.3. Cycle Offerings
- 11.9.4. Key Strategic Initiatives
- 11.9.5. SWOT Analysis
- 11.10. Kitazato Corporation
- 11.10.1. Company Snapshot
- 11.10.2. Financial Performance
- 11.10.3. Cycle Offerings
- 11.10.4. Key Strategic Initiatives
- 11.10.5. SWOT Analysis
- 11.11. Rocket Medical plc
- 11.11.1. Company Snapshot
- 11.11.2. Financial Performance
- 11.11.3. Cycle Offerings
- 11.11.4. Key Strategic Initiatives
- 11.11.5. SWOT Analysis
- 11.12. Hamilton Thorne Ltd.
- 11.12.1. Company Snapshot
- 11.12.2. Financial Performance
- 11.12.3. Cycle Offerings
- 11.12.4. Key Strategic Initiatives
- 11.12.5. SWOT Analysis
- 11.13. ZEISS Group
- 11.13.1. Company Snapshot
- 11.13.2. Financial Performance
- 11.13.3. Cycle Offerings
- 11.13.4. Key Strategic Initiatives
- 11.13.5. SWOT Analysis
- 11.14. FERTIPRO NV
- 11.14.1. Company Snapshot
- 11.14.2. Financial Performance
- 11.14.3. Cycle Offerings
- 11.14.4. Key Strategic Initiatives
- 11.14.5. SWOT Analysis
- 11.15. Gynotec B.V.
- 11.15.1. Company Snapshot
- 11.15.2. Financial Performance
- 11.15.3. Cycle Offerings
- 11.15.4. Key Strategic Initiatives
- 11.15.5. SWOT Analysis
- *The List of Company Is Subject to Change During the Final Compilation of The Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
